Literature DB >> 14760715

Proteomic analysis of lung biopsies: Differential protein expression profile between peritumoral and tumoral tissue.

Patricia Alfonso1, Myriam Catalá, María Luisa Rico-Morales, Gonzalo Durante-Rodríguez, Ernesto Moro-Rodríguez, Héctor Fernández-García, José M Escribano, Emilio Alvarez-Fernández, Eduardo García-Poblete.   

Abstract

The cellular proteome shows a dynamic profile and is subjected to changes in response to various stimuli and disease progression. Lung cancer remains the leading cause of cancer death in industrialized countries. In an attempt to find new disease markers, patients suffering from lung carcinoma have been selected to achieve differential protein expression patterns between normal and neoplasic tissue. After two-dimensional electrophoresis, the spots of interest were digested and identified by matrix-assisted laser desorption/ionization (MALDI) peptide mass fingerprinting. This information will provide a more comprehensive understanding of the disease progression and might constitute a method to complement histopathological diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14760715     DOI: 10.1002/pmic.200300647

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

1.  Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma.

Authors:  Paul B Romesser; David H Perlman; Douglas V Faller; Catherine E Costello; Mark E McComb; Gerald V Denis
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

Review 2.  Mass spectrometry-based proteomic profiling of lung cancer.

Authors:  Sebahat Ocak; Pierre Chaurand; Pierre P Massion
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

3.  Silencing of CT120 by antisense oligonucleotides could inhibit the lung cancer cells growth.

Authors:  Z Li; S Shao; S Xie; F Jiao; Y Ma; S Shi
Journal:  Ir J Med Sci       Date:  2009-12-20       Impact factor: 1.568

4.  SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents.

Authors:  Warren Fiskus; Veena Coothankandaswamy; Jianguang Chen; Hongwei Ma; Kyungsoo Ha; Dyana T Saenz; Stephanie S Krieger; Christopher P Mill; Baohua Sun; Peng Huang; Jeffrey S Mumm; Ari M Melnick; Kapil N Bhalla
Journal:  Cancer Res       Date:  2016-08-08       Impact factor: 12.701

5.  Study of distinct protein profiles for early diagnosis of NSCLC using LCM and SELDI-TOF-MS.

Authors:  Shuanying Yang; Yandong Nan; Yingxuan Tian; Wei Zhang; Bin Zhou; Lina Bu; Shufen Huo; Guoan Chen; Jiekai Yu; Shu Zheng
Journal:  Med Oncol       Date:  2008-02-26       Impact factor: 3.064

6.  Differential expression and subcellular localization of Prohibitin 1 are related to tumorigenesis and progression of non-small cell lung cancer.

Authors:  Ping Jiang; Yang Xiang; Yan-Jie Wang; Si-Man Li; Yan Wang; Hai-Rong Hua; Guo-Yu Yu; Yong Zhang; Wen-Hui Lee; Yun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

7.  Improving Detection Accuracy of Lung Cancer Serum Proteomic Profiling via Two-Stage Training Process.

Authors:  Pei-Sung Hsu; Yu-Shan Wang; Su-Chen Huang; Yi-Hsien Lin; Chih-Chia Chang; Yuk-Wah Tsang; Jiunn-Song Jiang; Shang-Jyh Kao; Wu-Ching Uen; Kwan-Hwa Chi
Journal:  Proteome Sci       Date:  2011-04-17       Impact factor: 2.480

8.  Application of serum SELDI proteomic patterns in diagnosis of lung cancer.

Authors:  Shuan-ying Yang; Xue-yuan Xiao; Wang-gang Zhang; Li-juan Zhang; Wei Zhang; Bin Zhou; Guoan Chen; Da-cheng He
Journal:  BMC Cancer       Date:  2005-07-20       Impact factor: 4.430

9.  Classification of premalignant pancreatic cancer mass-spectrometry data using decision tree ensembles.

Authors:  Guangtao Ge; G William Wong
Journal:  BMC Bioinformatics       Date:  2008-06-11       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.